Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
نویسندگان
چکیده
منابع مشابه
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
A though type 2 diabetes is a heterogeneous condition encompassing multiple metabolic and vascular alterations, it can be easily described as a disease characterized by chronic hyperglycemia and increased cardiovascular (CV) risk. Hyperglycemia is the diagnostic criterion for diabetes, the target for antidiabetic therapy, and, together with A1C, the marker of glycemic control. Progressive worse...
متن کاملIs There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
D iabetes induces a high degree of morbidity and significant reduction of life expectancy in affected subjects. Microvascular complications include retinopathy, nephropathy, and neuropathy, which frequently are underlying factors of major morbidity and disability associated with diabetes. However, macrovascular complications, and mainly cardiovascular disease, are still the leading causes of de...
متن کاملWhy Believe That There Is a God?
This article presents an argument for the existence of God, showing that the evident phenomena are best explained by supposing that a God causes them. The argument is based on the inductive force of four very evident general phenomena: that there is a physical Universe; that it is governed by very simple natural laws; that those laws are such as to lead to the existence of human bodies; and tha...
متن کاملIs there evidence that competition in healthcare is a good thing? Yes.
The coalition government’s approach to competition in the English NHS represents a shift to a more systematic attempt to organise the NHS along the line of the former publicly owned utilities. There is to be supplier competition both in the market (providers seeking individual patients) and for the market (commissioners selecting providers for services to populations). But the market for tax fi...
متن کاملThe use of oral hypoglycemic agents.
This DESG Teaching Letter was written by the DESG Executive commitee: Executive commitee: Dr. J.M. BOAVIDA, MD, Lisbon – Portugal (President); Dr. A. BROOKS, MD, Winchester – UK (Vice-President); Dr. I. HARMAN-BOEHM, MD, Sheva – Israel. (Director Educational Strategies); Ms. D. VARAKLA, Athens – Greece (Honorary Secretary); Dr. A. BALDELLI, MD, Rome – Italy (Honorary Treasurer); Dr. R. CHLUP, M...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetes Care
سال: 2009
ISSN: 0149-5992,1935-5548
DOI: 10.2337/dc09-s336